Rintatolimod
Term · Oncology and biomedicine · MLC-T-ONC-016550
A synthetic derivative of inosinic acid with antiretroviral and immunomodulatory properties. Atvogen acts through a number of pathways to stimulate intracellular antiviral activity of the immune system: it stimulates interferon production; activates the oligoadenylate synthase-RNase L pathway; stimulates natural killer cell activity; and acts as a non-mitogenic stimulator of the immune system. This agent also inhibits replication of human immunodeficiency virus (HIV) in vitro.
| Identifier | MLC-T-ONC-016550 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | atvogen |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-016550",
"term": "Rintatolimod",
"field": "Oncology and biomedicine",
"definition": "A synthetic derivative of inosinic acid with antiretroviral and immunomodulatory properties. Atvogen acts through a number of pathways to stimulate intracellular antiviral activity of the immune system: it stimulates interferon production; activates the oligoadenylate synthase-RNase L pathway; stimulates natural killer cell activity; and acts as a non-mitogenic stimulator of the immune system. This agent also inhibits replication of human immunodeficiency virus (HIV) in vitro.",
"synonyms": [
"atvogen"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/rintatolimod/"
}
Record 14,492 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.